Evidence map›Paper›PMID 42583341›Full record

ArticleJournal of thoracic disease2026

Feasibility, acceptability, and preliminary impact of a text messaging intervention to increase the uptake of lung cancer screening among Latinos: single-arm pilot study.

Jeffrey W Ramos-Santiago, Rafael H Orfin, Mary Jo Evans, Maria Delgado Sutton, Francisca Barria López, Arlette Chávez-Iñiguez, Gabriella Alvarez, Scott McIntosh, David H Adler, Beau W Abar and 6 more

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jeffrey W Ramos-SantiagoDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-1488-1027
Rafael H OrfinDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-9671-3253
Mary Jo EvansDepartment of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Maria Delgado SuttonLatinos Unidos Contra Cáncer, Cancer Support Community at Gilda's Club Rochester, Rochester, NY, USA.
Francisca Barria LópezDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Arlette Chávez-IñiguezDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-6799-2804
Gabriella AlvarezDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Scott McIntoshDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-5776-9617
David H AdlerDepartment of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0002-8797-1621
Beau W AbarDepartment of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0003-1536-220X
Dongmei LiClinical and Translational Science Institute, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0001-9140-2483
Alejandra Hurtado-de-MendozaGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.ORCID https://orcid.org/0000-0003-1086-8869
Lisa Carter-BawaCenter for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ, USA.ORCID https://orcid.org/0000-0002-6448-6033
M Patricia RiveraDepartment of Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0003-3827-5010
Ana Paula CupertinoDepartment of Surgery, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0001-7594-969X
Francisco Cartujano-BarreraDepartment of Environmental Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0000-0001-8069-1750

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
University of Rochester Wilmot Cancer Institute Support GrantP30CA272302 · NCI · UNIVERSITY OF ROCHESTER · PI JONATHAN W FRIEDBERG · 2025 to 2026
$6.4M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
NCATS NIH HHS UL1 TR000042NCI NIH HHS P30 CA272302NCI NIH HHS T32 CA102618
6 · The paper itself

Abstract

Background: Latinos, the largest minority group in the USA, have particularly low rates of lung cancer screening uptake. Although significant barriers exist, there is an overall strong interest in screening among Latinos when access is facilitated. Latinos have the highest rate of text messaging use in the USA and have expressed strong interest in participating in cancer prevention studies using text messages. No study has assessed the effectiveness of text messages to increase lung cancer screening uptake. The purpose of this study was to assess the feasibility, acceptability, and preliminary impact of Methods: This was a single-arm pilot study with 40 Latinos who were eligible for lung cancer screening but had not completed their annual screening. Participants were recruited using clinic- and community-based efforts. Results: At baseline, participants had a mean age of 59.1 years [standard deviation (SD) =6.5], 50% were women, 57.5% preferred Spanish, and 52.5% had a high school education or less. More than half of participants (65%) had never heard of lung cancer screening and 72.5% were unaware of their eligibility. Thirty-five participants (87.5%) completed the follow-up assessment at Month 3. The self-reported lung cancer screening rate was 20% (8/40). The electronic health record-verified lung cancer screening rate was 25% (10/40). Thirteen participants (32.5%; 13/40) completed the shared decision-making process. Thirty participants (90.9%, 30/33) reported being satisfied with the intervention and all participants (100%, 33/33) indicated they would recommend it to a friend or family member. Conclusions: It is feasible to recruit and retain Latinos in a lung cancer screening study.

Indexed as

LatinosLung cancer screeningtext messages

Identifiers

PMID42583341
PMCPMC13460230

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.